Honorary Professor Vicki Whitehall
Honorary Professor

Vicki Whitehall

Email: 

Availability

Honorary Professor Vicki Whitehall is:
Available for supervision

Qualifications

  • Bachelor of Science, The University of Queensland
  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Vicki Whitehall’s works on UQ eSpace

108 works between 1999 and 2023
All (108) Journal Article (70) Conference Publication (37) Other Outputs (1)

1 - 20 of 108 works

2023

Journal Article

Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer

Ramsay, Robert G., Whitehall, Vicki and Flood, Michael P. (2023). Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer. Growth Factors, 41 (4), 179-191. doi: 10.1080/08977194.2023.2227274

Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer

2023

Journal Article

The therapeutic landscape for KRAS-Mutated colorectal cancers

Tria, Simon Manuel, Burge, Matthew E. and Whitehall, Vicki L. J. (2023). The therapeutic landscape for KRAS-Mutated colorectal cancers. Cancers, 15 (8) 2375. doi: 10.3390/cancers15082375

The therapeutic landscape for KRAS-Mutated colorectal cancers

2023

Journal Article

The efficacy of using patient-derived organoids to predict treatment response in colorectal cancer

Su, Chang, Olsen, Kelly A., Bond, Catherine E. and Whitehall, Vicki L. J. (2023). The efficacy of using patient-derived organoids to predict treatment response in colorectal cancer. Cancers, 15 (3) 805, 1-16. doi: 10.3390/cancers15030805

The efficacy of using patient-derived organoids to predict treatment response in colorectal cancer

2022

Conference Publication

Proof of principle that loss of mismatch repair protein reduces tumor burden in mouse model of gastric cancer

Huber, Anne, Dijkstra, Christine, Whitehall, Vicki, Ernst, Matthias and Eissmann, Moritz (2022). Proof of principle that loss of mismatch repair protein reduces tumor burden in mouse model of gastric cancer. AACR Special Conference: Tumor Immunology and Immunotherapy, Boston, MA United States, 21-24 October 2022. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/2326-6074.tumimm22-a49

Proof of principle that loss of mismatch repair protein reduces tumor burden in mouse model of gastric cancer

2022

Journal Article

Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis

Fennell, Lochlan J., Hartel, Gunter, McKeone, Diane M., Bond, Catherine E., Kane, Alexandra, Leggett, Barbara A., Patch, Ann-Marie and Whitehall, Vicki L.J. (2022). Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis. Cell Reports Methods, 2 (11) 100323, 1-14. doi: 10.1016/j.crmeth.2022.100323

Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis

2022

Journal Article

Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

Luk, Ian Y., Jenkins, Laura J., Schoffer, Kael L., Ng, Irvin, Tse, Janson W. T., Mouradov, Dmitri, Kaczmarczyk, Stanislaw, Nightingale, Rebecca, Burrows, Allan D., Anderson, Robin L., Arango, Diego, Dopeso, Higinio, Croft, Larry, Richardson, Mark F., Sieber, Oliver M., Liao, Yang, Mooi, Jennifer K., Vukelic, Natalia, Reehorst, Camilla M., Afshar-Sterle, Shoukat, Whitehall, Vicki L. J., Fennell, Lochlan, Abud, Helen E., Tebbutt, Niall C., Phillips, Wayne A., Williams, David S., Shi, Wei, Mielke, Lisa A., Ernst, Matthias ... Mariadason, John M. (2022). Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. Cell Death and Differentiation, 29 (11), 2288-2302. doi: 10.1038/s41418-022-01016-w

Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

2021

Journal Article

Global methylome scores correlate with histological subtypes of colorectal carcinoma and show different associations with common clinical and molecular features

Turpín‐sevilla, María Del Carmen, Pérez‐sanz, Fernando, García‐solano, José, Sebastián‐león, Patricia, Trujillo‐santos, Javier, Carbonell, Pablo, Estrada, Eduardo, Tuomisto, Anne, Herruzo, Irene, Fennell, Lochlan J., Mäkinen, Markus J., Rodríguez‐braun, Edith, Whitehall, Vicki L. J., Conesa, Ana and Conesa‐zamora, Pablo (2021). Global methylome scores correlate with histological subtypes of colorectal carcinoma and show different associations with common clinical and molecular features. Cancers, 13 (20) 5165, 5165. doi: 10.3390/cancers13205165

Global methylome scores correlate with histological subtypes of colorectal carcinoma and show different associations with common clinical and molecular features

2021

Conference Publication

Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer

Su, C., Bond, C., Fennell, L., Kerr, G., Jarde, T., Micati, D., Engel, R., Chan, W. H., Hlavca, S., Archer, S., Mcmurrick, P., Hammerlindl, H., Lim, F., Salik, B., Mckeone, D., Hartel, G., Leggett, B., Schaider, H., Abud, H., Boyle, G., Burge, M. and Whitehall, V. (2021). Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer. HOBOKEN: WILEY.

Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer

2021

Journal Article

Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium

Fennell, Lochlan, Kane, Alexandra, Liu, Cheng, McKeone, Diane, Hartel, Gunter, Su, Chang, Bond, Catherine, Bettington, Mark, Leggett, Barbara and Whitehall, Vicki (2021). Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium. Gut, 71 (6) 322166, 1127-1140. doi: 10.1136/gutjnl-2020-322166

Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium

2021

Journal Article

Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment

Borowsky, Jennifer, Haruki, Koichiro, Lau, Mai Chan, Costa, Andressa Dias, Vayrynen, Juha P., Ugai, Tomotaka, Arima, Kota, Da Silva, Annacarolina, Felt, Kristen D., Zhao, Melissa, Gurjao, Carino, Twombly, Tyler S., Fujiyoshi, Kenji, Vayrynen, Sara A., Hamada, Tsuyoshi, Mima, Kosuke, Bullman, Susan, Harrison, Tabitha A., Phipps, Amanda I., Peters, Ulrike, Ng, Kimmie, Meyerhardt, Jeffrey A., Song, Mingyang, Giovannucci, Edward L., Wu, Kana, Zhang, Xuehong, Freeman, Gordon J., Huttenhower, Curtis, Garrett, Wendy S. ... Ogino, Shuji (2021). Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment. Clinical Cancer Research, 27 (10), 2816-2826. doi: 10.1158/1078-0432.CCR-20-4009

Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment

2021

Journal Article

Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia

Kane, Alexandra M., Liu, Cheng, Fennell, Lochlan J., McKeone, Diane M., Bond, Catherine E., Pollock, Pamela M., Young, Graeme, Leggett, Barbara A. and Whitehall, Vicki L. J. (2021). Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia. British Journal of Cancer, 124 (11), 1820-1827. doi: 10.1038/s41416-021-01339-4

Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia

2021

Journal Article

Curcumin chemoprevention reduces the incidence of Braf mutant colorectal cancer in a preclinical study

Kane, Alexandra M., Liu, Cheng, Akhter, Dewan T., McKeone, Diane M., Bell, Craig A., Thurecht, Kristofer J., Leggett, Barbara A. and Whitehall, Vicki L. J. (2021). Curcumin chemoprevention reduces the incidence of Braf mutant colorectal cancer in a preclinical study. Digestive Diseases and Sciences, 66 (12), 4326-4332. doi: 10.1007/s10620-020-06752-y

Curcumin chemoprevention reduces the incidence of Braf mutant colorectal cancer in a preclinical study

2020

Journal Article

PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer

Cuda, Tahleesa J., Riddell, Andrew D., Liu, Cheng, Whitehall, Vicki L., Borowsky, Jennifer, Wyld, David K., Burge, Matthew E., Ahern, Elizabeth, Griffin, Alison, Lyons, Nicholas J. R., Rose, Stephen E., Clark, David A., Stevenson, Andrew R. L., Hooper, John D., Puttick, Simon and Thomas, Paul A. (2020). PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. The Journal of Nuclear Medicine, 61 (11), 1576-1579. doi: 10.2967/jnumed.119.233312

PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer

2020

Journal Article

Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study

Kuchel, Anna, Ahern, Elizabeth, Collins, Stephanie, Whitehall, Vicki, Okano, Satomi, Pelecanos, Anita, Wyld, David, Eastgate, Melissa and Burge, Matthew (2020). Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study. Asia-Pacific Journal of Clinical Oncology, 17 (1) ajco.13420, 84-93. doi: 10.1111/ajco.13420

Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study

2020

Journal Article

APC mutation marks an aggressive subtype of BRAF mutant colorectal cancers

Fennell, Lochlan J., Kane, Alexandra, Liu, Cheng, McKeone, Diane, Fernando, Winnie, Su, Chang, Bond, Catherine, Jamieson, Saara, Dumenil, Troy, Patch, Ann-Marie, Kazakoff, Stephen H., Pearson, John V., Waddell, Nicola, Leggett, Barbara and Whitehall, Vicki L. J (2020). APC mutation marks an aggressive subtype of BRAF mutant colorectal cancers. Cancers, 12 (5) 1171, 1-26. doi: 10.3390/cancers12051171

APC mutation marks an aggressive subtype of BRAF mutant colorectal cancers

2020

Journal Article

Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease:

Miller, Gregory C., Liu, Cheng, Bettington, Mark L., Leggett, Barbara, Whitehall, Vicki L.J. and Rosty, Christophe (2020). Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease:. Human Pathology, 97, 19-28. doi: 10.1016/j.humpath.2019.12.005

Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease:

2020

Journal Article

Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer

Kane, Alexandra M., Fennell, Lochlan J., Liu, Cheng, Borowsky, Jennifer, McKeone, Diane M., Bond, Catherine E., Kazakoff, Stephen, Patch, Ann-Marie, Koufariotis, Lambros T., Pearson, John, Waddell, Nicola, Leggett, Barbara A. and Whitehall, Vicki L.J. (2020). Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer. Neoplasia, 22 (2), 120-128. doi: 10.1016/j.neo.2019.12.002

Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer

2019

Conference Publication

Intestinal epigenetic age and risk of sessile serrated adenoma progression to cancer

Fennell, L., Kane, A., Mckeone, D., Bond, C., Leggett, B. and Whitehall, V. (2019). Intestinal epigenetic age and risk of sessile serrated adenoma progression to cancer. HOBOKEN: WILEY.

Intestinal epigenetic age and risk of sessile serrated adenoma progression to cancer

2019

Conference Publication

Aspirin reduces the incidence of metastatic Braf mutant colorectal cancer in a preclinical trial

Kane, A., Mckeone, D., Liu, C., Borowsky, J., Leggett, B. and Whitehall, V. (2019). Aspirin reduces the incidence of metastatic Braf mutant colorectal cancer in a preclinical trial. HOBOKEN: WILEY.

Aspirin reduces the incidence of metastatic Braf mutant colorectal cancer in a preclinical trial

2019

Journal Article

BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions

Bettington, Mark, Liu, Cheng, Gill, Anthony, Walker, Neal, Leggett, Barbara, Whitehall, Vicki and Rosty, Christophe (2019). BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions. Histopathology, 75 (1), 81-87. doi: 10.1111/his.13851

BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions

Availability

Honorary Professor Vicki Whitehall is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Improving Immunotherapy Efficacy for Colorectal Cancer

    Principal Advisor

    Other advisors: Professor David Clark

  • Doctor Philosophy

    Personalised Medicine for Colorectal Cancer

    Principal Advisor

    Other advisors: Professor David Clark

Completed supervision

Enquiries

For media enquiries about Honorary Professor Vicki Whitehall's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au